1. Home
  2. SBCF vs CLDX Comparison

SBCF vs CLDX Comparison

Compare SBCF & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seacoast Banking Corporation of Florida

SBCF

Seacoast Banking Corporation of Florida

N/A

Current Price

$33.98

Market Cap

3.3B

Sector

Finance

ML Signal

N/A

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

N/A

Current Price

$36.90

Market Cap

3.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SBCF
CLDX
Founded
1926
N/A
Country
United States
United States
Employees
N/A
198
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.0B
IPO Year
2009
1995

Fundamental Metrics

Financial Performance
Metric
SBCF
CLDX
Price
$33.98
$36.90
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$38.00
$46.60
AVG Volume (30 Days)
749.7K
684.9K
Earning Date
04-28-2026
05-04-2026
Dividend Yield
2.43%
N/A
EPS Growth
10.56
N/A
EPS
0.84
N/A
Revenue
N/A
$12,743,000.00
Revenue This Year
$45.04
$111.39
Revenue Next Year
$6.30
$235.85
P/E Ratio
$40.31
N/A
Revenue Growth
N/A
87.78
52 Week Low
$28.58
$22.10
52 Week High
$36.27
$45.14

Technical Indicators

Market Signals
Indicator
SBCF
CLDX
Relative Strength Index (RSI) 45.14 42.99
Support Level $32.83 $28.51
Resistance Level $34.50 $40.30
Average True Range (ATR) 0.65 1.26
MACD -0.10 -0.37
Stochastic Oscillator 43.13 18.54

Price Performance

Historical Comparison
SBCF
CLDX

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: